Kuros Biosciences AG

Fr 19.54As of Sun 8 Nov 2026, 12:00 UTC
SWX:KURNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR 1.94%
Div yield —
ROE 10.73%
Medical Devices
Beta (5Y) 0.72
PE TTM 111.0
TSR TTM (34.87%)
Mkt cap Fr 778.2M
ROIC 9.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 22
14.79%
(95.24%)
Hold 2|8|10|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.26
0.25
0.27
6.60%
3.93%
5.45%
8.16%
Revenue$M
66.36
68.71
70.41
72.49
13.99%
12.09%
8.66%
13.57%
Peers (US$954.4M)
Cap (US$)
PE
1.673B
91.41x
1.553B
—
457.4M
—
959.0M
247.4x
Capital
TTM
5Y
10Y
Leveragex
0.730
0.014
0.011
EBIT/Intx
11.90
0.261
0.240
Own earn%
172.17
30.58
23.45
Sh yield%
36.84
22.95
24.92
Owners
Insiders/Inst%
4.30
76.24
Short interest%
2.18
SBC / revenue%
4.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
21